A total of 148 drugs have been newly included in a revised list of drugs covered by China’s basic medical insurance, work-related injury insurance as well as childbirth insurance that was launched on Tuesday.
The updated drug list marked a major step to improve medical security of the nation and relieve the drug cost burden of insured individuals, according to Xiong Xianjun, chief of the medical services administration department of National Healthcare Security Administration.
Out of the 148 new drugs, five are for major diseases treatment, 36 for chronic diseases like diseases, and 38 medicines for children use. In total, the list covers 2,643 drugs and is set to take effect on Jan 1, 2020.
Elsewhere, 128 exclusive drugs, which are of high clinical value but quite expensive, have been identified following expert reviews as potential inclusions to the list, subject to negotiations with their respective manufacturers.